Maybe that's true with today's technology. But that stuff tends to improve, especially if you invest money/research.
One would so assume, but I saw a statement that whole classes of medications(?) seen as promising in the 90s were a no go because of the exact same fundamental bioreactor scaling issues. I’ll try to find the reference.
Not the original reference I was thinking of, but close enough: